Burgess I. Human lice and their control. Ann Rev Entomol. 2004;49:457-481.
American Academy of Pediatrics; Devore CD, Schutze GE. Head lice. Pediatrics. 2015;135:e1355-e1365.
Meinking TL. Infestations: pediculosis. Curr Probl Dermatol. 1999;11:73-120.
Mumcuoglu KY, Meinking TA, Burkhart CN, et al. Head louse infestations: the "no nit" policy and its consequences. Int J Derm. 2006;45:891-896.
1. Burgess IF, Silverston P. Head lice. Clin Evid (Online). January 2015. http://clinicalevidence.bmj.com (last accessed 2 November 2016).
2. Burgess I. Human lice and their control. Ann Rev Entomol. 2004;49:457-481.
3. Ko CJ, Elston DM. Pediculosis. J Am Acad Dermatol. 2004;50:1-14.
4. Leung AK, Fong JH, Pinto-Rojas A. Pediculosis capitis. J Ped Health Care. 2005;19:369-373.
5. Counahan M, Andrews R, Buttner P, et al. Head lice prevalence in primary schools in Victoria, Australia. J Paediatr Child Health. 2004;40:616-619.
6. Harris J, Crawshaw JG, Millership S. Incidence and prevalence of head lice in a district health authority area. Commun Dis Public Health. 2003;6:246-249.
7. Fan CK, Liao CW, Wu MS, et al. Prevalence of pediculus capitis infestation among school children of Chinese refugees residing in mountainous areas of northern Thailand. Kaohsiung J Med Sci. 2004;20:183-187.
8. American Academy of Pediatrics; Devore CD, Schutze GE. Head lice. Pediatrics. 2015;135:e1355-e1365.
9. Downs A, Oxley J. Head lice infestations in different ethnic groups. Int J Derm. 2001;40:237-240.
10. Lesshafft H, Baier A, Guerra H, et al. Prevalence and risk factors associated with pediculosis capitis in an impoverished urban community in lima, peru. J Glob Infect Dis. 2013;5:138-143.
11. Meinking TL. Infestations: pediculosis. Curr Probl Dermatol. 1999;11:73-120.
12. Gratz NG; World Health Organization/WHOPES. Human lice: their prevalence, control and resistance to insecticides - a review, 1985-1997. August 1997. http://whqlibdoc.who.int (last accessed 2 November 2016).
13. Houhamdi L, Parola P, Raoult D. Les poux et les maladies transmises à l’homme [in French]. Médecine Tropicale. 2005;65:1-11.
14. Feldmeier H. Lice as vectors of pathogenic microorganisms. In: Heukelbach J, ed. Management and control of head lice infestation. Bremen: UNIMED; 2010:132-135.
15. Boutellis A, Mediannikov O, Bilcha KD, et al. Borrelia recurrentis in head lice, Ethiopia. Emerg Infect Dis. 2013;19:796-798.
16. Antinori S, Mediannikov O, Corbellino M, et al. Louse-borne relapsing fever among East African refugees in Europe. Travel Med Infect Dis. 2016;14:110-114.
17. Speare R, Thomas G, Cahill C. Head lice are not found on floors in primary school classrooms. Aus N Z J Pub Health. 2002;26:208-211.
18. Heukelbach J, Wilcke T, Winter B, et al. Epidemiology and morbidity of scabies and pediculosis capitis in resource-poor communities in Brazil. Br J Derm. 2005;153:150-156.
19. Estrada JS, Morris RI. Pediculosis in a school population. J Sch Nurs. 2000;16:32-38.
20. Willems S, Lapeere H, Haedens N, et al. The importance of socio-economic status and individual characteristics on the prevalence of head lice in schoolchildren. Eur J Dermatol. 2005;15:387-392.
21. Chunge RN, Scott FE, Underwood JE, et al. A pilot study to investigate transmission of head lice. Can J Public Health. 1991;82:207-208.
22. Maunder JW. Human lice: some basic facts and misconceptions. Bull Pan Am Health Organ. 1985;19:194-197.
23. Burkhart CN. Fomite transmission with head lice: a continuing controversy. Lancet. 2003;361:99-100.
24. Burkhart CN, Burkhart CG. Fomite transmission in head lice. J Am Acad Derm. 2007;56:6.
25. Speare R, Cahill C, Thomas G. Head lice on pillows, and strategies to make a small risk even less. Int J Derm. 2003;42:626-629.
26. Williams LK, Reichert A, MacKenzie WR, et al. Lice, nits, and school policy. Pediatrics. 2001;107:1011-1015.
27. Mumcuoglu KY, Meinking TA, Burkhart CN, et al. Head louse infestations: the "no nit" policy and its consequences. Int J Derm. 2006;45:891-896.
28. American Academy of Pediatrics. Head lice. In: 2006 Red Book: report of the committee on infectious diseases. 27:448-492.
29. Public Health Medicine Environmental Group. Head lice: evidence-based guidelines based on the Stafford Report - 2012 update [internet publication].
30. Mumcuoglu KY, Friger M, Ioffe-Uspensky I, et al. Louse comb versus direct visual examination for the diagnosis of head louse infestations. Ped Derm. 2001;18:9-12.
31. Burgess I. Detection combing. Nurs Times. 2002;98:57.
32. Pollack RJ, Kiszewski AD, Spielman A. Overdiagnosis and consequent mismanagement of head louse infestation in North America. Pediatr Infect Dis J. 2000;19:689-693.
33. Jahnke C, Bauer E, Hengge UR, et al. Accuracy of diagnosis of pediculosis capitis: visual inspection vs wet combing. Arch Dermatol. 2009;145:309-313.
34. Balcioglu C, Burgess IF, Limoncu ME, et al. Plastic detection comb better than visual screening for diagnosis of head louse infestation. Epidemiol Infect. 2008;136:1425-1431.
35. Hootman J. Quality improvement projects related to pediculosis management. J School Nursing. 2002;18:80-86.
36. Feldmeier H. Pediculosis capitis: new insights into epidemiology, diagnosis and treatment. Eur J Clin Microbiol Infect Dis. 2012;31:2105-2110.
37. Pollack RJ. The role of the school in battling head lice. Our children (US National PTA). 2007. http://www.pta.org (last accessed 2 November 2016).
38. Jones KN, English JC. Review of common therapeutic options in the United States for the treatment of Pediculosis capitis. Clin Inf Dis. 2003;36:1355-1361.
39. Downs AM. Managing head lice in an era of increasing resistance to insecticides. Am J Clin Derm. 2004;5:160-177.
40. Meinking TL, Entzel P, Villar ME, et al. Comparative efficacy of treatments for Pediculosis capitis infestations. Arch Dermatol. 2001;137:287-292.
41. Burkhart CG, Burkhart CN. Safety and efficacy of pedulicides for head lice. Expert Opin Drug Saf. 2006;5:169-171.
42. Burkhart CG, Burkhart CN. Head lice therapies revisited. Derm Online J. 2006;12:3.
43. Burkhart CG. Relationship of treatment-resistant head lice to the safety and efficacy of pediculicides. Mayo Clin Proc. 2004;79:661-666.
44. Lebwohl M, Clark L, Levitt J. Therapy for head lice based on life cycle, resistance, and safety considerations. Pediatrics. 2007;119:965-974.
45. Do-Pham G, Le Cleach L, Giraudeau B, et al. Designing randomized-controlled trials to improve head-louse treatment: systematic review using a vignette-based method. J Invest Dermatol. 2014;134:628-634.
46. Feldmeier H. Treatment of pediculosis capitis: a critical appraisal of the current literature. Am J Clin Dermatol. 2014;15:401-412.
47. Kristensen M, Knorr M, Rasmussen AM, et al. Survey of permethrin and malathion resistance in human head lice populations from Denmark. J Med Entomol. 2006;43:533-538.
48. Kasai S1, Ishii N, Natsuaki M, Fukutomi H, et al. Prevalence of kdr-like mutations associated with pyrethroid resistance in human head louse populations in Japan. J Med Entomol. 2009;46:77-82.
49. Hunter JA, Barker SC. Susceptibility of head lice (Pediculus humanus capitis) to pediculicides in Australia. Parasitol Res. 2003;90:476-478.
50. Durand R, Millard B, Bouges-Michel C, et al. Detection of pyrethroid resistance gene in head lice in schoolchildren from Bobigny, France. J Med Entomol. 2007;44:796-798.
51. Bailey AM, Prociv P. Persistent head lice following multiple treatments: evidence for insecticide resistance in Pediculus humanus capitis. Australas J Dermatol. 2000;41:250-254.
52. Sendzik J, Stahlmann R. Arzneimittel gegen Kopflausbefall. Toxikologie und Wirksamkeit [in German]. Med Monatsschr. Pharm 2005; 28: 167-172
53. Menegaux F, Baruchel A, Bertrand Y, et al. Household exposure to pesticides and risk of childhood acute leukaemia. Occup Environ Med. 2006;63:131-134.
54. US Food and Drug Administration. FDA public health advisory: safety of topical lindane products for the treatment of scabies and lice. 2009. http://www.fda.gov (last accessed 2 November 2016).
55. Takano-Lee M, Edman JD, Mullens BA, et al. Home remedies to control head lice: assessment of home remedies to control the human head louse, Pediculus humanus capitis. J Ped Nursing. 2004;19:393-398.
56. Priestley CM, Burgess IF, Williamson EM. Lethality of essential oil constituents towards the human louse, Pediculus humanus, and its eggs. Fitoterapia. 2006;77:303-309.
57. Speare R, Canyon DV, Cahill C, et al. Comparative efficacy of two nit combs in removing head lice (Pediculosis capitis) and their eggs. Int J Dermatol. 2007;46:1275-1278.
58. Lapeere H, Brochez L, Verhaeghe E, et al. Efficacy of products to remove eggs of Pediculus humanus capitis (Phthiraptera: Pediculidae) from the human hair. J Med Entomol. 2014;51:400-407.
59. Bainbridge CV, Klein GL, Neibart SI, et al. Comparative study of the clinical effectiveness of a pyrethrin-based pediculicide with combing versus a permethrin-based pediculicide with combing. Clin Pediatr (Phila). 1998;37:17-22.
60. Plastow L, Luthra M, Wright J, et al. Head lice infestation: bug busting vs traditional treatment. J Clin Nursing. 2001;10:775-783.
61. Tebruegge M, Runnacles J. Is wet combing effective in children with pediculosis capitis infestation? Arch Dis Child. 2007;92:818-820.
62. Monheit BM, Norris MM. Is combing the answer to head lice? J Sch Health. 1986;56:158-159.
63. O'Brien E. Detection and removal of head lice with an electronic comb: zapping the louse! J Pediatr Nurs. 1998;13:265-266.
64. Burkhart CN, Burkhart CG, Pchalek I, et al. The adherent cylindrical nit structure and its chemical denaturation in vitro: an assessment with therapeutic implications for head lice. Adolesc Med. 1998;152:711-712.
65. DeFelice J, Rumsfield J, Bernstein JE, et al. Clinical evaluation of an after-pediculicide nit removal system. Int J Dermatol. 1989;28:468-470.
66. Goates BM, Atkin JS, Wilding KG, et al. An effective nonchemical treatment for head lice: a lot of hot air. Pediatrics. 2006;118:1962-1970.
67. Heukelbach J, Oliveira FA, Richter J, et al. Dimeticone-based pediculicides: a physical approach to eradicate head lice. Open Dermatol J. 2010;4:77-81.
68. Richling I, Böckeler W. Lethal effects of treatment with a special dimeticone formula on head lice and house crickets (Orthoptera, Ensifera: Acheta domestica and Anoplura, phthiraptera: Pediculus humanus). Insights into physical mechanisms. Arzneimittelforschung. 2008;58:248-254.
69. Burgess IF. The mode of action of dimeticone 4% lotion against head lice, Pediculus capitis. BMC Pharmacol. 2009;9:3.
70. Kurt O, Balcioğlu IC, Burgess IF, et al. Treatment of head lice with dimeticone 4% lotion: comparison of two formulations in a randomised controlled trial in rural Turkey. BMC Public Health. 2009;9:441.
71. Burgess IF, Brunton ER, Burgess NA. Single application of 4% dimeticone liquid gel versus two applications of 1% permethrin creme rinse for treatment of head louse infestation: a randomised controlled trial. BMC Dermatol. 2013;13:5.
72. Burgess IF, Brown CM, Lee PN. Treatment of head louse infestation with 4% dimeticone lotion: randomised controlled equivalence trial. BMJ. 2005;330:1423-1425.
73. Heukelbach J, Pilger D, Oliveira FA, et al. A highly efficacious pediculicide based on dimeticone: randomized observer blinded comparative trial. BMC Infect Dis. 2008;8:115.
74. Burgess IF1, Lee PN, Matlock G. Randomised, controlled, assessor blind trial comparing 4% dimeticone lotion with 0.5% malathion liquid for head louse infestation. PLoS One. 2007;2:e1127.
75. Strycharz JP, Yoon KS, Clark JM. A new ivermectin formulation topically kills permethrin-resistant human head lice (Anoplura: Pediculidae). J Med Entomol. 2008;45:75-81.
76. Heukelbach J, Sonnberg S, Becher H, et al. Ovicidal efficacy of high concentration dimeticone: a new era of head lice treatment. J Am Acad Dermatol. 2011;64:e61-2.
77. Burgess IF, Burgess NA. Dimeticone 4% liquid gel found to kill all lice and eggs with a single 15 minute application. BMC Res Notes. 2011;4:15.
78. Pearlman DL. A simple treatment for head lice: dry-on, suffocation-based pediculicide. Pediatrics. 2004;112:e275-e279.
79. Pearlman D. Cetaphil cleanser (Nuvo Lotion) cures head lice. Pediatrics. 2005;116:1612.
80. Meinking TL, Vicaria M, Eyerdam DH, et al. A randomized, investigator-blinded, time-ranging study of the comparative efficacy of 0.5% malathion gel versus Ovide Lotion (0.5% malathion) or Nix Creme Rinse (1% permethrin) used as labeled, for the treatment of head lice. Ped Derm. 2007;24:405-411.
81. Meinking TL, Vicaria M, Eyerdam DH, et al. Efficacy of a reduced application time of Ovide lotion (0.5% malathion) compared to Nix creme rinse (1% permethrin) for the treatment of head lice. Ped Derm. 2004;21:670-674.
82. Yoon KS, Gao JR, Lee SH, et al. Permethrin-resistant human head lice, Pediculus capitis, and their treatment. Arch Dermatol. 2003;139:994-1000.
83. Meinking TL, Serrano L, Hard B, et al. Comparative in vitro pediculicidal efficacy of treatments in a resistant head lice population in the United States. Arch Dermatol. 2002;138:220-224.
84. Abramowicz M, ed. Drugs for head lice. Med Lett Drugs Ther. 1997;39:6-7.
85. Pollack RJ, Kiszewski A, Armstrong P, et al. Differential permethrin susceptibility of head lice sampled in the United States and Borneo. Arch Pediatr Adolesc Med. 1999;153:969-973.
86. Burgess IF, Lee PN, Brown CM. Randomised, controlled, parallel group clinical trials to evaluate the efficacy of isopropyl myristate/cyclomethicone solution against head lice. Pharm J. 2008;280:371-375.
87. Kaul N, Palma KG, Silagy SS, et al. North American efficacy and safety of a novel pediculicide rinse, isopropyl myristate 50% (Resultz). J Cutan Med Surg. 2007;11:161-167.
88. Chosidow O, Giraudeau B, Cottrell J, et al. Oral ivermectin versus malathion lotion for difficult-to-treat head lice. New Engl J Med. 2010;362:896-905.
89. POEMs Research Summaries. Ivermectin safe and effective for treatment of resistant head lice. J Natl Med Assoc. 2010;102:662-663.
90. Karacic I, Yawalker SJ. A single application of crotamiton lotion in the treatment of patients with pediculosis capitis. Int J Dermatol. 1982;21:611-613.
91. Burgess IF, Lee PN, Kay K, et al. 1,2-Octanediol, a novel surfactant, for treating head louse infestation: identification of activity, formulation, and randomised, controlled trials. PLoS One. 2012;7:e35419.
92. Burgess IF, Burgess NA, Brunton ER. Tocopheryl acetate 20% spray for elimination of head louse infestation: a randomised controlled trial comparing with 1% permethrin creme rinse. BMC Pharmacol Toxicol. 2013;14:43.
93. National Association of School Nurses (US). Head lice management in the school setting: position statement. January 2016. http://www.nasn.org (last accessed 2 November 2016).
使用此内容应接受我们的免责声明。
BMJ临床实践的持续改进离不开您的帮助和反馈。如果您发现任何功能问题和内容错误,或您对BMJ临床实践有任何疑问或建议,请您扫描右侧二维码并根据页面指导填写您的反馈和联系信息*。一旦您的建议在我们核实后被采纳,您将会收到一份小礼品。
如果您有紧急问题需要我们帮助,请您联系我们。
邮箱:bmjchina.support@bmj.com
电话:+86 10 64100686-612
*您的联系信息仅会用于我们与您确认反馈信息和礼品事宜。
BMJ临床实践官方反馈平台